Gene · 80310
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA miR-145-5p Inhibits Cutaneous Wound Healing by Targeting PDGFD in Diabetic Foot Ulcer. | Biochem Genet | 2024 | 37950842 | PubTator, text mining | PubMed |
| Molecular evolution of wound healing-related genes during cetacean secondary aquatic adaptation. | Integr Zool | 2024 | 37897119 | PubTator, text mining | PubMed |
| Development of a prognostic signature for immune-associated genes in bladder cancer and exploring potential drug findings. | Int Urol Nephrol | 2024 | 37740848 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/PDGFR-β Mediated Paracrine Signaling Network. | Aging Dis | 2024 | 37307823 | PubTator, text mining | PubMed |
| Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. | Mol Cell Biochem | 2024 | 37016182 | PubTator, text mining | PubMed |
| Genetic alterations in the neuronal development genes are associated with changes of the tumor immune microenvironment in pancreatic cancer. | Ann Pancreat Cancer | 2023 | 38495381 | PubTator, text mining | PubMed |
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. | Pharmaceuticals (Basel) | 2023 | 38275995 | PubTator, text mining | PubMed |
| The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment. | Front Pharmacol | 2023 | 38269274 | PubTator, text mining | PubMed |
| Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment. | Front Chem | 2023 | 38264122 | PubTator, text mining | PubMed |
| Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer. | Cancers (Basel) | 2023 | 38136368 | PubTator, text mining | PubMed |
| Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies. | Cancers (Basel) | 2023 | 38136324 | PubTator, text mining | PubMed |
| Phenotypic Characterization of 2D and 3D Prostate Cancer Cell Systems Using Electrical Impedance Spectroscopy. | Biosensors (Basel) | 2023 | 38131796 | PubTator, text mining | PubMed |
| Mapping the protein-protein interactome in the tumor immune microenvironment. | Antib Ther | 2023 | 38098892 | PubTator, text mining | PubMed |
| Space microgravity increases expression of genes associated with proliferation and differentiation in human cardiac spheres. | NPJ Microgravity | 2023 | 38071377 | PubTator, text mining | PubMed |
| Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease. | Stem Cells Int | 2023 | 38034060 | PubTator, text mining | PubMed |
| A Comprehensive Bioinformatics Approach to Identify Molecular Signatures and Key Pathways for the Huntington Disease. | Bioinform Biol Insights | 2023 | 38033382 | PubTator, text mining | PubMed |
| MYLK and CALD1 as molecular targets in bladder cancer. | Medicine (Baltimore) | 2023 | 38013282 | PubTator, text mining | PubMed |
| Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma. | J Pers Med | 2023 | 38003931 | PubTator, text mining | PubMed |
| Advances in Intercellular Communication Mediated by Exosomal ncRNAs in Cardiovascular Disease. | Int J Mol Sci | 2023 | 38003385 | PubTator, text mining | PubMed |
Three Diseases Mediated by Different Immunopathologic Mechanisms-ANCA-Associated Vasculitis, Anti-Glomerular Basement Membrane Disease, and Immune Complex-Mediated Glomerulonephritis-A Common Clinical and Histopathologic Picture: Rapidly Progressive Crescentic Glomerulonephritis. | Biomedicines | 2023 | 38001978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/papers?page=5